Navigation Links
Patients and scientists join forces to tackle Friedreich's Ataxia
Date:11/14/2013

Barcelona, Thursday 14 November 2013.- The Spanish Federation of Ataxia (FEDAES)in representation of the GENEFA Platform for a Friedreich's Ataxia cure, the Babel Family association for biomedical research into Friedreich's Ataxia, the "Centro de Biologa Molecular Severo Ochoa" (CMBSO), and the Institute for Research in Biomedicine (IRB Barcelona) have signed an agreement through which these patients' associations will fund, by means of donations, a 3-year research project addressing Friedreich's Ataxia.

Friedreich's Ataxia is a rare degenerative disease of the nervous system that affects coordination, balance and movement. It is a monogenic disease, that is to say, it is caused by a defect in only one gene. Those affected by this disorder have inherited an altered frataxin gene from both parents. The project aims to develop molecular tools to transport a correct copy of the defective gene to all the cells of the body and particularly to a kind of neuron that undergoes degeneration and causes the disease. This approach seeks to restore the normal levels of frataxin and to stop the manifestation of the degenerative symptoms of the disease.

The GENEFA Platform heads the money-raising campaign to collect the 300,000 euros required to develop this gene therapy project. Juan Carlos Baiges, in representation of FEDAES/GENEFA and the Babel Family for this project, expresses his enthusiasm, "it is the first step towards achieving an effective treatment based on solid basic research knowledge", and adds, "we have a motivating project ahead that may lead us closer to a treatment."

Ernest Giralt, at IRB Barcelona, and Javier Daz-Nido, at CBMSO, scientific co-leaders of the project, stress that, "it is uncommon for basic researchers to have direct contact with patients and this project is fantastic because it reminds us that the solutions to diseases derive from basic research, the cornerstone of future applications."

A SINGLE
'/>"/>

Contact: Sònia Armengou
armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Reproductive health providers should discuss environmental exposure risks with patients
2. Low-calorie diet may be harmful for bowel disease patients
3. Interventional radiology: Mitigating symptoms, improving quality of life of MS patients
4. Interventional radiologists see significant symptom relief in MS patients
5. Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
6. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
7. Obese patients face higher radiation exposure from CT scans -- but new technology can help
8. Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
9. Transcatheter aortic valve implantation shows promise in patients with severe aortic stenosis
10. Urgent research needed to determine most effective follow-up care for lung cancer patients
11. Gene signature helps identify risk of relapse in lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Patients and scientists join forces to tackle Friedreich's Ataxia
(Date:8/19/2014)... MA -- MIT chemical engineers have devised a new ... are released slowly over a few weeks. When applied ... the body to rapidly form new bone that looks ... type of coated scaffold could offer a dramatic improvement ... involves transplanting bone from another part of the patient,s ...
(Date:8/19/2014)... today,s crocodiles colonised the seas during warm phases and ... Anglo-French study which establishes a link between marine crocodilian ... period of more than 140 million years. , ... Universit de Lyon, France and formerly from the University ... Nature Communications ., Today, crocodiles are ,cold-blooded, animals that ...
(Date:8/19/2014)... A team of UTSA researchers has been awarded a ... Technology and Training (NCPTT), an office of the National ... The grant will fund a one-year study of the ... of historic homes in hot, humid climates. , Radiant ... or attics that reflect heat back, thereby reducing the ...
Breaking Biology News(10 mins):Engineering new bone growth 2Engineering new bone growth 3Evolution of marine crocodilians constrained by ocean temperatures 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3
... Angeles New evidence from the University of Southern California ... that help compile small bits of information in order to ... professor of psychology in the area of brain and cognitive ... Public Library of Science journal, PLoS ONE. It ...
... MA--Boston University School of Medicine (BUSM) will present The Sixth ... 14, 2007 at noon. The annual lecture is in honor ... in BUSMs Pulmonary Center. Kim Hanson, along with her ... the second plane that struck the World Trade Center on ...
... University of Oregon has received a $1.6 million grant ... effects of exposure to precisely engineered nanoparticles that are ... three-year grant from the Keck Foundations medical research program ... Andy Berglund, all UO professors of chemistry; UO biology ...
Cached Biology News:Shape encoding may start in the retina 2Lecture to honor victim of Sept. 11 tragedy 2Keck Foundation funds study of biological interactions with nanomaterials 2
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ... today reported results of its Oral Amphotericin B ... reservoirs.  The study, conducted by ImmuneCarta®, the immune ... vitro effectiveness of Oral Amp B in ... in individuals despite intensive treatment with antiretroviral therapy. ...
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... According to the new ... (Municipal Wastewater Treatment and Industrial Wastewater Treatment), By ... By Configuration (Internal/Submerged and External/Sidestream), and By Region-Trends ... market for membrane bioreactor systems is projected to ... CAGR of 15.28% between 2014 and 2019. ...
(Date:8/16/2014)... NY (PRWEB) August 16, 2014 ... industry provide guidance and advisory services to ... and technical issues. Industry services are highly diverse ... Therefore, industry services range from geological and geophysical ... plans. “Consequently, over the past five years, the ...
Breaking Biology Technology:iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 2Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 3
... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced today ... broadcast live over the Internet on Thursday, July 23, 2009, at ... results will be made available at 7:00 a.m. the morning of ... be accessed via Zimmer,s Investor Relations website at ...
... Pa. and NEWTON, Mass., June 30 Microfluidics, ... (OTC Bulletin Board: MFLU), and Particle Sciences Inc. ... biopharmaceutical companies leverage the most advanced and reliable ... and commercialize Active Pharmaceutical Ingredients (APIs). , ...
... June 30 Hospira, Inc. (NYSE: HSP ... today announced agreements with MedAssets on intravenous (I.V.) solutions ... agreement for infusion devices. The five-year MedAssets agreements are ... and equipment, and July 1, 2009, for infusion devices. ...
Cached Biology Technology:Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement 2
...
... measures NOS activity by monitoring the conversion ... is simple, sensitive, and specific for NOS ... crude and purified enzyme preparations. The kit ... total reactions. Radiolabeled arginine and NADPH are ...
Human TSLP MAb (Clone 258136)...
Human Complement Component C5a MAb (Clone 295003)...
Biology Products: